Hanall Biopharma Co., Ltd. (009420.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Hanall Biopharma Co., Ltd.
Address
43, Sangseodang 1-gil
Daejeon, DE 04386
Korea (the Republic of)
Phone
+82 2 6440 7000
Website
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
315
First IPO Date
January 04, 2000
Key Executives
| Name | Title | Pay | Year Born |
| Su-Jin Park | Co-CEO, VP & Director | 0 | 1972 |
| Sean Jeong | President, Co-CEO & Director | 0 | 1971 |
| Nam-Yong Cho | Senior Executive Director of Sales & Marketing and Senior Managing Director | 0 | 1954 |
| David Hernandez | VP & Head of Clinical Development Operations | 0 | N/A |
| Christopher W. Slavinsky | Chief Business Development & Legal Officer | 0 | 1973 |
| SeongUn Kim | Head of Business Management Division | 0 | 1980 |
| Hye Kyung Ahn | Head of Research Division | 0 | 1971 |
| Jae-Seung Yoon | C.V.O | 0 | 1962 |
AD
Description
HANALL BIOPHARMA Co., Ltd. engages in the manufacture and sale of synthetic drug and biopharmaceuticals. It offers products such as medicine for digestion, high blood pressure, cerebrovascular disease, myocardial infarction, anti-diabetics, antibiotics, gastrointestinal, bone structure, erectile dysfunction, hives, and other pharmaceutical products. The company was founded by Byeong-Tae Kim on November 20, 1973 and is headquartered in Daejeon, South Korea.
AD
